All Harvest One Medicinal Products Sold Online
to Begin Carrying
BLOCKStrain-Verified Seal of Authenticity
VANCOUVER, Feb. 14, 2019 /CNW/ - BLOCKStrain Technology
Corp. (TSX:V: DNAX) (OTC: BKKSF) ("BLOCKStrain"),
creator of the first Blockchain-secured, fully-integrated IP
tracking platform for the cannabis industry, today announced that
Harvest One Cannabis Inc. (TSX:V: HVT) (OTCQX: HRVOF) ("Harvest
One"), a Canadian licensed producer of medical cannabis, will
employ BLOCKStrain's proprietary genome tracking software to
collect and register its cannabis plant DNA and strains.
By incorporating BLOCKStrain's cannabis strain authenticity and
tracking platform - the Master Genome Strain and Clone
Registration Program - into its sales program, Harvest One is
expected to be able to confirm its medical cannabis strains are as
labelled, providing its consumers with increased transparency and
confidence about its products. Upon completion of the collection
and registration of its strains, an initial 30 Harvest One products
will carry BLOCKStrain's Seal of Authenticity, guaranteeing their
origin and providing quality assurance.
"This agreement with Harvest One is a testament to the growing
traction of our proprietary genome-to-sale software, which we
expect to increase as more companies recognize the inherent and
significant value in protecting the genetics and IP of their
various strains," said BLOCKStrain's Chief Executive Officer,
Robert Galarza. "We believe our
unique technology will enable Harvest One to guarantee its strains
and provide consumers with unparalleled assuredness about the
products they purchase. This is of particular importance for
medical cannabis when patients with specific conditions are relying
on products to be of consistent quality and provide consistent
results."
"BLOCKStrain's technology is intended to enable us to guarantee
that our strain origins and content are exactly as labelled,
providing medical consumers with a level of certainty they could
not expect with similar, unverified products," said Grant Froese, Chief Executive Officer of Harvest
One. "This increased level of quality control is in keeping with
our mission build a global house of brands, providing lifestyle and
wellness health products to consumers and patients in regulated
markets."
About BLOCKStrain's Master Genome Strain & Clone
Registration Program:
Under its Master Genome Strain & Clone Registration Program
(the "Program"), BLOCKStrain's team collects plant data and
performs genomic sequencing in plant batches which are then
registered in a blockchain-enabled database for intellectual
property protection and strain validation. BLOCKStrain believes all
information gathered from the plants, including their molecular and
chemical makeup, can be tracked via the Program. Going forward, it
is expected that a quick response (QR) barcode specific to each
plant batch will be able to reveal, among other things, how a plant
was cloned and cultivated, and its cannabinoid content. A video
introducing the WeedMD and BLOCKStrain pilot project, representing
the first example of commercial use of the Program, can be found
here.
About BLOCKStrain:
BLOCKStrain has developed the first integrated blockchain
platform to register and track intellectual property in the
cannabis industry. BLOCKStrain's technology allows cannabis growers
and breeders to identify and secure rights to their intellectual
property. It also streamlines the administrative process and
reduces the costs of genetic and mandatory quality-control testing
for legal cannabis. BLOCKStrain's technology is proprietary,
immutable and cryptographically secure, thereby establishing a
single-source, accurate, validated, and permanent account for
cannabis strains from ownership to market.
About Harvest One:
Harvest One is a global cannabis company that develops and
provides innovative lifestyle and wellness products to consumers
and patients in regulated markets around the world. Its range of
lifestyle solutions is designed to enhance quality of life.
Shareholders have significant exposure to the entire cannabis value
chain through three wholly-owned subsidiaries: United
Greeneries, a Licensed Producer; Satipharm (medical and
nutraceutical); and Dream Water Global (consumer), and a
minority interest in Burb Cannabis (retail operations). For
more information, please visit www.harvestone.com.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES
PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX
VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR
ACCURACY OF THIS RELEASE
Disclaimer for Forward-Looking Information
This press release contains "forward-looking information"
within the meaning of applicable Canadian securities legislation
which are based upon the current internal expectations, estimates,
projections, assumptions and beliefs, and views of future events,
of BLOCKStrain and Harvest One. Forward-looking information can be
identified by the use of forward-looking terminology such as
"expect", "likely", "may", "will", "should", "intend",
"anticipate", "potential", "proposed", "estimate" and other similar
words. Forward-looking information in this news release is based
upon the expectations, estimates, projections, assumptions and
views of future events which management of BLOCKStrain and Harvest
One believe to be reasonable in the circumstances and includes
statements that: BLOCKStrain's technology is expected to provide
consumers with increased transparency and confidence; that more
companies will recognize the value of using the Program; and the
expectation that Harvest One will be able to guarantee its strains
are exactly as labelled and provide consumers with unparalleled
assuredness about its products. Forward-looking information
includes estimates, plans, expectations, opinions, forecasts,
projections, targets, guidance and other statements that are not
statements of fact. Forward-looking information necessarily
involves known and unknown risks, including risks associated with
the failure of the Program to work as expected; general economic
conditions; adverse industry events; loss of markets; future
legislative and regulatory developments; inability to access
sufficient capital from internal and external sources, and/or
inability to access sufficient capital on favourable terms; the
cannabis industry in Canada
generally; the ability of BLOCKStrain to implement its business
strategies; competition; and other risks. Such forward-looking
information is provided as of the date hereof and BLOCKStrain and
Harvest One disclaim any intent or obligation to update publicly
any such forward-looking information, whether as a result of new
information, future events or results or otherwise, except as
required by applicable securities laws.
SOURCE BLOCKStrain Technology Corp.